The potential effect of statins on rituximab immunotherapy.

The potential effect of statins on rituximab immunotherapy.

Bibliographic Details
Main Author:	Mark S Cragg
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2008-03-01
Series:	PLoS Medicine
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18366253/pdf/?tool=EBI

Similar Items

The potential effect of statins on rituximab immunotherapy
by: Cragg, Mark S.
Published: (2008)

Statins and immunotherapy: Togetherness makes strength The potential effect of statins on immunotherapy for NSCLC
by: Alessandro Rossi, et al.
Published: (2021-08-01)

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20.
by: Magdalena Winiarska, et al.
Published: (2008-03-01)

Statins Do Not Influence Long-Term Rituximab Clinical Efficiency in Rheumatoid Arthritis Patients
by: Diana Mazilu, et al.
Published: (2014-01-01)

Rituximab Iodination Procedure for Radioiodinated Rituximab (131I-Rituximab) Preparation
by: Martalena Ramli, et al.
Published: (2019-06-01)

Statins in Asthma: Potential Beneficial Effects and Limitations
by: Dipanjan Bhattacharjee, et al.
Published: (2015-01-01)

Potential Effect of Statins on Mycobacterium tuberculosis Infection
by: Paola Del Carmen Guerra-De-Blas, et al.
Published: (2018-01-01)

RITUXIMAB: NEW POTENTIALITIES OF THERAPY FOR RHEUMATOID ARTHRITIS
by: D E Karateev, et al.
Published: (2008-12-01)

Targeted Immunotherapy with Rituximab Leads to a Transient Alteration of the IgG Autoantibody Profile in Pemphigus Vulgaris
by: Ralf Müller, et al.
Published: (2010-01-01)

Cardiac side effect of rituximab
by: Vaibhav Bansidhar Patil, et al.
Published: (2020-01-01)

Potential role of statins in COVID-19
by: Ken Cheah Hooi Lee, et al.
Published: (2020-07-01)

Statins as potential therapeutic drug for asthma?
by: Yuan Cheng, et al.
Published: (2012-11-01)

Severe CMV infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in an old mantle cell lymphoma patient
by: Gabriele Magliano, et al.
Published: (2021-08-01)

Effectiveness of rituximab in nephrotic syndrome treatment
by: Katarzyna Popko, et al.
Published: (2017-10-01)

Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathways
by: Jennifer Edelmann, et al.
Published: (2021-02-01)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
by: Sonia Boyer-Suavet, et al.
Published: (2020-01-01)

Rituximab: historia, farmacología y perspectivas Rituximab: history, pharmacology and perspectives
by: Edgardo E. Espinosa Estrada, et al.
Published: (2010-12-01)

Pharmacological actions of statins: potential utility in COPD
by: T. E. Eaton, et al.
Published: (2009-12-01)

Potential molecular targets of statins in the prevention of hepatocarcinogenesis
by: Ezequiel Ridruejo, et al.
Published: (2018-05-01)

Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial
by: Zinzani Pier, et al.
Published: (2012-10-01)

Effects of Statins on Bone
by: Merih Eryavuz Sarıdoğan, et al.
Published: (2003-09-01)

Pleiotropic effects of statins
by: Narasaraju Kavalipati, et al.
Published: (2015-01-01)

The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins
by: Huanbiao Mo, et al.
Published: (2019-01-01)

RITUXIMAB IN PEDIATRIC RHEUMATOLOGY
by: E.I. Alexeeva, et al.
Published: (2010-05-01)

Rituximab in dermatology: Revisited
by: Aditya Kumar Bubna
Published: (2020-01-01)

Commentary: Rituximab in scleritis
by: Parthopratim Dutta Majumder
Published: (2020-01-01)

RITUXIMAB IN PEDIATRIC RHEUMATOLOGY
by: E.I. Alexeeva, et al.
Published: (2010-01-01)

Rituximab in Membranous Nephropathy
by: Philipp Gauckler, et al.
Published: (2021-04-01)

B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab
by: Wiesik-Szewczyk E, et al.
Published: (2012-09-01)

Rituximabe na síndrome de Felty refratária Rituximab in the refractory Felty's syndrome
by: Thiago Sotero Fragoso, et al.
Published: (2009-04-01)

Lenalidomide plus rituximab Vs rituximab alone in relapsed or refractory indolent lymphoma: A cost‐effectiveness analysis
by: Peng‐Fei Zhang, et al.
Published: (2020-08-01)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
by: Joanna Tieu, et al.
Published: (2021-05-01)

Is rituximab effective for induction of remission in lupus nephritis?
by: Macarena Mac-Namara, et al.
Published: (2014-08-01)

Rituximab Not Effective for Hearing Loss in Cogan’s Syndrome
by: Daniel R. Bunker, et al.
Published: (2016-01-01)

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases
by: Aniek Lamberts, et al.
Published: (2018-02-01)

Effect of rituximab on heart involvement in systemic sclerosis
by: L. A. Garzanova, et al.
Published: (2019-01-01)

PREDICTION OF TOCILIZUMAB AND RITUXIMAB EFFECTIVENESS IN RHEUMATOID ARTHRITIS
by: Volkava M. V.
Published: (2019-11-01)

Implications on the Therapeutic Potential of Statins via Modulation of Autophagy
by: Armita Mahdavi Gorabi, et al.
Published: (2021-01-01)

The potential role of statins in the treatment and prevention of oesophageal adenocarcinoma
by: Alexandre, Leo
Published: (2017)

Rhodococcus erythropolis Encephalitis in Patient Receiving Rituximab
by: Satish R. Bagdure, et al.
Published: (2012-08-01)

Cannot write session to /tmp/vufind_sessions/sess_od2q8lst7r2otv28gicrg1guib